In celebration of Ophthalmology Times 50th anniversary, we asked leading experts in the field what they see as the biggest ...

The novel nitric oxide-donating bimatoprost eye drop is being clinically developed for the lowering of IOP in patients with ...

ZEISS VISULAS Combi is an advanced therapeutic laser workstation offering photodisruption, photocoagulation, and slit lamp ...

Labtician Ophthalmics has announced the commercial launch of Lab TRIACTIV, an artificial tear designed to redefine dry eye ...

Pantheon Vision’s bioengineered corneal implant aims to tackle issues with the success rate of human donated tissue.

UBX1325 is a novel BCL-xL inhibitor designed to eliminate senescent cells in diabetic retinal blood vessels, while leaving ...

Aurion is developing AURN001, a clinical-stage allogeneic cell therapy asset, for corneal edema secondary to corneal ...

Refractive cataract surgery has been transformed by advanced IOL technology, including extended and full-range vision lenses, ...

Patients reported that Miebo significantly reduced overall symptoms severity at the primary endpoint of change from baseline ...

Epi-on corneal crosslinking is advancing through innovations like supplemental oxygen, chemical oxygenation, and ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

An AI model for target IOP prediction performs as well as glaucoma specialists, offering a promising tool to enhance glaucoma ...